x

75% of people globally want unbiased news (Pew Research) but are concerned they're not getting that.

Get balanced coverage with Symby. See how stories are covered across diverse outlets and spot when one side covers a story the other skips.

PODCAST

Diabetes Dialogue: Technology, Therapeutics, & Real-World Perspectives

Diabetes Dialogue: Technology, Therapeutics, & Real-World Perspectives

Diabetes Dialogue: Technology, Therapeutics, & Real-World Perspectives is a podcast hosted by Drs. Diana Isaacs and Natalie Bellini aimed at providing a regular roundup of the latest clinically applicable insights across diabetes and metabolic diseases, with a focus on leveraging technology to improve care. A video version of each episode is available at HCPLive.com/Clinical/Endocrinology. Please direct podcast-related inquiries to PCampbell@MJHLifesciences.com. Editor"s note: Episodes

health & fitness medicine

All Episodes

20:40

Hot Topics and Updates from ATTD 2024

Diabetes Dialogue: Technology, Therapeutics, &... ·

2024/03/30

In the third and final recap episode from the 17th annual International Conference on Advanced Technologies & Treatments for Diabetes, hosts of Diabetes Dialogue: Technology, Therapeutics, & Real-World Perspectives Diana Isaacs, PharmD, and Natalie Bellini, DNP, take a deep dive into a series of topics from the meeting, including GLP-1 receptor agonist use and CGM technology, updates in once-weekly insulins, the concept of continuous ketone monitoring, and application of artificial

en-us

8:29

T1D Glycemic Improvement and CRISTAL at ATTD 2024

Diabetes Dialogue: Technology, Therapeutics, &... ·

2024/03/26

In this episode, hosts provide insight from automated insulin delivery updates from the 17th annual International Conference on Advanced Technologies & Treatments for Diabetes. The specific topics of note covered in this study include new data related to diabetes technology use from the Type 1 Diabetes (T1D) Exchange and a read-out of data from the CRISTAL trial.

en-us

29:52

FLOW Trial and Chronic Kidney Disease Updates, with...

Diabetes Dialogue: Technology, Therapeutics, &... ·

2024/03/22

In this episode of Diabetes Dialogue: Technology, Therapeutics, & Real-World Perspectives hosts are joined by Brendon Neuen, MBBS, PhD, nephrologist and director of the Kidney Trials Unit at Royal North Shore Hospital and senior research fellow at The George Institute for Global Health. During the episode, Neuen talks about the FLOW trial, topline results, how the rapid advancement in pharmacotherapies has altered conversations around management, the concept of 4 pillars of GDMT for CKD in

en-us

28:26

Dexcom Stelo and CGM Updates, with Jake Leach

Diabetes Dialogue: Technology, Therapeutics, &... ·

2024/03/22

Hosts of Diabetes Dialogue: Technology, Therapeutics, & Real-World Perspectives recorded a special edition episode with Jake Leach, chief operating officer of Dexcom. The episode itself represents a follow-up to a conversation a year ago at International Conference on Advanced Technologies & Treatments for Diabetes (ATTD) 2023, where Leach discussed the ongoing global rollout of the Dexcom G7 and how he expected expanded coverage of the device to open doors to greater personalization of care

en-us

24:52

Tirzepatide and the Future of Incretin Therapies,...

Diabetes Dialogue: Technology, Therapeutics, &... ·

2024/03/18

W. Timothy Garvey, MD, professor of medicine and director of the Diabetes Research Center at the University of Alabama at Birmingham and the principal investigator of SURMOUNT-2, joins our hosts to provide perspective on several topics, including the FDA’s approval of tirzepatide for chronic weight management, data from the SURMOUNT-2, -3, and 4 programs, the future of incretin therapies, and more. Key Timestamps 01:04 - Guest Introduction 03:45 - FDA Indication for Obesity 08:45 -

en-us

24:40

SELECT, Semaglutide, & the Future of Incretin...

Diabetes Dialogue: Technology, Therapeutics, &... ·

2024/03/02

In this episode, hosts are joined by co-chair of the SELECT steering committee A. Michael Lincoff, MD, to discuss results, potential explanations for cardiovascular benefit of semaglutide 2.4 mg beyond weight reduction, FLOW trials implications, and the future of incretin therapies. Chapters: 00:35 - Guest Introduction 01:10 - SELECT Results Overview 04:25 - Next Steps for Research 07:15 - Mechanism of Action for CV Benefit 09:00 - FLOW Trial Implications 11:25 - Impact on Access 15:00 - Future of

en-us

21:43

Understanding MARD, Comparing Popular CGM Sensors

Diabetes Dialogue: Technology, Therapeutics, &... ·

2024/02/29

In this episode, the hosts breakdown a pair of recent publications related to better understanding the strengths and limitations of MARD as well as a study comparing the Dexcom G7 and FreeStyle Libre 3 sensors. Video version: https://www.hcplive.com/view/diabetes-dialogue-understanding-mard-comparing-popular-cgm-sensors Key Highlights: 00:35 - The Myth of MARD 04:10 - Considerations When Interpreting MARD 10:15 - FreeStyle Libre 3 vs. Dexcom G7

en-us

14:33

ATTD 2024 Preview

Diabetes Dialogue: Technology, Therapeutics, &... ·

2024/02/26

In the episode, hosts provide insight into sessions to watch, device news they are excited for, what makes ATTD a unique and valuable experience for the diabetes care team, and how the meeting’s annual yearbook session encapsulates the exciting developments within the field. Video Version: https://www.hcplive.com/view/diabetes-dialogue-attd-2024-preview Key Highlights: 01:05 - Bellini’s ATTD Picks 03:45 - Isaacs’ ATTD Picks 06:20 - Health Disparities in Focus 07:10 - Time in Tighter Range 10:20

en-us

15:14

Time in Range, CGM Metrics for Predicting Outcomes in...

Diabetes Dialogue: Technology, Therapeutics, &... ·

2024/02/20

The introduction of CGM in 1999 completely shifted the trajectory of care for people with diabetes. Now, new data suggest advanced CGM metrics, such as time in range, are proving comparable to HbA1c for predicting diabetic retinopathy and other microvascular outcomes.In this episode, Viral Shah, MD, joins Diabetes Dialogue to discuss a recent study examining associations between time in range and other advanced CGM metrics with diabetic retinopathy and the implications for use in predicting other

en-us

16:43

Tirzepatide in Type 1 Diabetes, with Viral Shah, MD

Diabetes Dialogue: Technology, Therapeutics, &... ·

2024/02/15

In this episode, hosts are joined by Shah for a discussion on his recent proof-of-concept study looking at tirzepatide in type 1 diabetes, the prospect of GLP-1 RA-based therapies in type 1 diabetes, and the potential roles for tirzepatide beyond T2D and weight management. Episode Highlights 00:00 - Intro 01:56 - Use of GLP-1s in T1D 05:32 - Study on Tirzepatide in T1D 10:04 - Insulin Use in Study 11:20 - Safety Outcomes

en-us

30:19

Diabetes Technology Updates in January 2024

Diabetes Dialogue: Technology, Therapeutics, &... ·

2024/01/10

In this episode, hosts discuss recent news and updates in diabetes technology from Abbott, Dexcom, and Medtronic in the first half of January 2024. Episode Highlights 00:40 Abbott FreeStyle Libre 2 Plus 18:08 Dexcom Stelo 26:30 Medtronic Simplera Sync

en-us

31:58

Updates in Management of Hypercortisolism in Type 2...

Diabetes Dialogue: Technology, Therapeutics, &... ·

2024/01/09

In this episode, hosts sit down with Ralph DeFronzo, MD, for a discussion on how advances in management have transformed the diagnosis and management of hypercortisolism among people with type 2 diabetes. Episode Highlights 00:39 DeFronzo Introduction 01:54 Presentation of Hypercortisolism 05:50 Ominous Octet and Hypercortisolism 09:47 Prevalence of Hypercortisolism in T2D 13:57 Impact of Untreated Hypercortisolism 17:05 Screening for Hypercortisolism 21:25 CATALYST Trial 31:30 Outro

en-us

19:42

Latest Updates on Diabetes Management in Pregnancy

Diabetes Dialogue: Technology, Therapeutics, &... ·

2024/01/08

In this episode, the hosts break down a pair of recent studies published in JAMA examining use of non-insulin agents in the management of diabetes during pregnancy. Episode Highlights 00:05 Intro 00:28 Episode Overview 02:00 GLP-1 RAs in Early Pregnancy 05:53 Implications of Results 10:30 Metformin in Early Pregnancy 13:48 Implications of Results

en-us

18:18

Baricitinib & the Potential Disease-Modifying...

Diabetes Dialogue: Technology, Therapeutics, &... ·

2024/01/03

Hosts discuss a recent study on baricitinib in type 1 diabetes, how these results compare to other data in this arena, and what all of these studies mean for future of type 1 diabetes management. Episode Highlights 00:05 Intro 01:20 Baricitinib Overview 02:30 BANDIT Trial Design 03:30 Trial Results 05:40 Delaying Type 1 Diabetes 14:45 Need for Screening 18:00 Outro

en-us

30:22

Diabetes Dialogue: 2023 Top Episodes Recap

Diabetes Dialogue: Technology, Therapeutics, &... ·

2024/01/01

To celebrate the end of 2023, hosts recap the top 10 episodes of the past year and offer perspective on how the news discussed in these episodes has shaped the future of diabetes management. Episode Highlights 00:32 Automated Insulin Delivery News in October 2023 04:35 Breaking Down AACE's New Type 2 Diabetes Management Algorithms 06:45 What Medicare Drug Price Negotiations Mean for Diabetes 09:15 STEP-HFpEF Reaction 12:10 Dexcom G7 and the Future of CGM, with Jake Leach 13:20 Tandem Mobi and

en-us

23:21

Key Updates in ADA Standards of Care—2024

Diabetes Dialogue: Technology, Therapeutics, &... ·

2023/12/29

Hosts discuss what they consider the most significant or relevant updates in the ADA's Standards of Care—2024, with a focus on new recommendations for glycemic management, bone health, immunizations, and weight management. Episode Highlights 0:05 Intro 1:04 Glycemic Management Updates 9:00 Bone Health Updates 13:30 Immunization and Vaccination Updates 15:35 Weight Management Updates 23:10 Outro

en-us

22:55

Diabetes Technology Updates and Standards of Care—2024

Diabetes Dialogue: Technology, Therapeutics, &... ·

2023/12/19

In this episode of Diabetes Dialogue: Technology, Therapeutics, & Real-World Perspectives, hosts Diana Isaacs, PharmD, and Natalie Bellini, DNP, discuss the latest in diabetes technology from December 2023, with a spotlight on announcements surrounding use of Dexcom’s G7 continuous glucose monitoring (CGM) system as well as the latest updates to the American Diabetes Association’s Standards of Care. Episode Highlights 0:05 Intro 0:42 AID Integrations with Dexcom G7 7:02 ADA Standards of Care

en-us

16:05

SELECT Proves Semaglutide 2.4 mg CV Benefit at AHA 2023

Diabetes Dialogue: Technology, Therapeutics, &... ·

2023/11/11

In this episode, hosts take a deep dive into the study’s results, including secondary endpoints, and what it means for the care of patients with overweight or obesity and preexisting cardiovascular disease in real-world settings.

en-us

14:34

Tirzepatide (Zepbound) Approved for Chronic Weight...

Diabetes Dialogue: Technology, Therapeutics, &... ·

2023/11/08

In this episode, hosts discuss the FDA's approval of tirzeptiade (Zepbound) as an adjunct to lifestyle modification for the chronic weight management in people with overweight or obesity.

en-us

24:55

Diabetes Dialogue: Automated Insulin Delivery News in...

Diabetes Dialogue: Technology, Therapeutics, &... ·

2023/11/01

In this episode, hosts discuss the FDA clearance of the Omnipod 5 App for iPhones and a pair of studies examining use of automated insulin delivery systems.

en-us

172 results

Similar Podcasts

Доктор Тройняшкин

Доктор Тройняшкин

The Dry Eye Treatment PODCAST

Dry Eye Treatment

Différent et alors ?

PATRICK SULAY

Kyle Kingsbury Podcast

Kyle Kingsbury

The Real Weight Loss Coach

Matty Lansdown